Loading clinical trials...
Loading clinical trials...
A Comparison of Oral Controlled-release Morphine With Transdermal Fentanyl in Nasopharyngeal Cancer Patients With Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy
Conditions
Interventions
Fentanyl
Morphine
Start Date
December 1, 2020
Primary Completion Date
December 1, 2021
Completion Date
December 1, 2021
Last Updated
July 29, 2020
NCT06980038
NCT06346132
NCT07482709
NCT07351968
NCT06946290
NCT07041736
Lead Sponsor
Jiarong Chen, MD
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions